Common use of Inventions, Discoveries and Patents Clause in Contracts

Inventions, Discoveries and Patents. The determination of rights in ownership and disposition of inventions resulting from the performance of the Statement of Work (“Subject Inventions”) and the administration of patents will be in accordance with 37 CFR 401 and the terms of this Subaward Agreement. Subrecipient shall disclose promptly to PTE any patentable Subject Inventions pursuant to the reporting requirements provided in Attachment 4. Publication Prior to enrollment of the first subject in the Study, PTE agrees to ensure that the Study is fully registered on ▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ in accordance with the requirements of the International Committee of Medical Journal Editors (ICMJE) and Public Law 110‐85 (42USC282). Results of this Study will be reported in compliance with applicable laws. Each party shall have the right to publish and disseminate information derived from the performance of the Statement of Work under this Subaward Agreement. Qualification for authorship shall be in keeping with generally accepted criteria. Subrecipient shall provide PTE with a copy of any proposed publication for review and comment at least thirty (30) days prior to submission. Activities, reports and publications resulting from this grant must adhere to the Acknowledgement standards set by the NIH. (▇▇▇▇://▇▇▇▇▇▇.▇▇▇.▇▇▇/grants/acknow.htm#requirements) ☐ This Study is part of a multi-center clinical trial. The Subrecipient agrees that the first Publication of the results of the Study shall be made in conjunction with the presentation of a joint multi‐center Publication of the Study results with the Principal Investigators from all sites contributing Data, analyses, and comments. However, Subrecipient may publish the Data and Study results individually in accordance with this Publication section upon first occurrence of one of the following: (i) multi‐center Publication is published; (ii) no multi‐center publication is submitted within twelve (12) months after conclusion, abandonment, or termination of the Study at all sites; or (iii) PTE confirms in writing there will be no multi‐center Publication. If no multi‐center Publication occurs within twelve (12) months of the completion of the Study at all sites, upon request by Subrecipient, PTE agrees to provide Subrecipient access to the aggregate Data from all Study sites.

Inventions, Discoveries and Patents. The determination of rights in ownership and disposition of inventions resulting from the performance of the Statement of Work (“Subject Inventions”) and the administration of patents will be in accordance with 37 CFR 401 and the terms of this Subaward Agreement. Subrecipient shall disclose promptly to PTE any patentable Subject Inventions pursuant to the reporting requirements provided in Attachment 4. Publication Prior to enrollment of the first subject in the Study, PTE agrees to ensure that the Study is fully registered on ▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ in accordance with the requirements of the International Committee of Medical Journal Editors (ICMJE) and Public Law 110‐85 (42USC282). Results of this Study will be reported in compliance with applicable laws. Each party shall have the right to publish and disseminate information derived from the performance of the Statement of Work under this Subaward Agreement. Qualification for authorship shall be in keeping with generally accepted criteria. Subrecipient shall provide PTE with a copy of any proposed publication for review and comment at least thirty (30) days prior to submission. Activities, reports and publications resulting from this grant must adhere to the Acknowledgement standards set by the NIH. NIH (▇▇▇▇://▇▇▇▇▇▇.▇▇▇.▇▇▇/grants/acknow.htm#requirements) ☐ ). This Study is part of a multi-center multi‐center clinical trial. The Subrecipient agrees that the first Publication of the results of the Study theStudy shall be made in conjunction with the presentation of a joint multi‐center Publication of the Study results with the Principal Investigators from all sites contributing Data, analyses, and comments. However, Subrecipient may publish the Data and Study results individually in accordance with this Publication section upon first occurrence of one of the following: (i) multi‐center Publication is published; (ii) no multi‐center publication is submitted within twelve (12) months after conclusion, abandonment, or termination of the Study at all sites; or (iii) PTE confirms in writing there will be no multi‐center Publication. If no multi‐center Publication occurs within twelve (12) months of the completion of the Study at all sites, upon request by Subrecipient, PTE agrees to provide Subrecipient access to the aggregate Data from all Study sites.